<code id='E8F123BB9A'></code><style id='E8F123BB9A'></style>
    • <acronym id='E8F123BB9A'></acronym>
      <center id='E8F123BB9A'><center id='E8F123BB9A'><tfoot id='E8F123BB9A'></tfoot></center><abbr id='E8F123BB9A'><dir id='E8F123BB9A'><tfoot id='E8F123BB9A'></tfoot><noframes id='E8F123BB9A'>

    • <optgroup id='E8F123BB9A'><strike id='E8F123BB9A'><sup id='E8F123BB9A'></sup></strike><code id='E8F123BB9A'></code></optgroup>
        1. <b id='E8F123BB9A'><label id='E8F123BB9A'><select id='E8F123BB9A'><dt id='E8F123BB9A'><span id='E8F123BB9A'></span></dt></select></label></b><u id='E8F123BB9A'></u>
          <i id='E8F123BB9A'><strike id='E8F123BB9A'><tt id='E8F123BB9A'><pre id='E8F123BB9A'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          entertainment

          author:entertainment    - browse:2
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus